Greater Weight Loss Found With SGLT-2 Inhibitors Than GLP-1 RAs in Patients with T2D
Aug 7, 2021
Editor: David L. Joffe, BSPharm, CDE, FACA
Author: Kornelia Ilias, Pharm.D. Candidate, Creighton University School of Pharmacy and Health Professions
Contrary to previous studies, new research finds SGLT-2i more effective for weight loss than GLP-1 RAs as add-on therapy to Metformin.
Patients with T2D frequently struggle with excess weight, contributing to the development of comorbidities and worsened outcomes. Guidelines from the American Diabetes Association (ADA) and the American Association of Clinical Endocrinologists (AACE) recommended using patient-specific parameters for selecting additiona…